TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr | ₹577 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹281 Cr |
Mar2023 | ₹688 Cr |
Mar2022 | ₹544 Cr |
Mar2021 | ₹744 Cr |
Mar2020 | ₹577 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹281 Cr | -59.20 | |
Mar2023 | ₹688 Cr | 26.44 | |
Mar2022 | ₹544 Cr | -26.83 | |
Mar2021 | ₹744 Cr | 29.01 | |
Mar2020 | ₹577 Cr | - |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,005.4 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
MANKIND PHARMA | ₹104,071.0 Cr | 7.6% | 16.3% | 2.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.7% |
4% |
25.1% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses